WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Wednesday, May 25, 2016

PhotoPharmics Investigating Efficacy of Phototherapy for Parkinson’s Disease

May 25, 2016

Daniela Semedo, PhD


PhotoPharmics, Inc. is currently conducting a pivotal study to demonstrate the safety and efficacy of specialized phototherapy for the treatment of  Parkinson’s disease (PD).
Accumulating evidence shows that the eyes are involved in the development of Parkinson’s disease, since PD patients have damaged retinal dopamine neurons. Recent discoveries show a link between these neurons and the substantia nigra, and that damage to one area causes corresponding damage to the other.
In a series of experiments, investigators placed into animals’ eyes several toxins known to cause Parkinson’s in amounts too small to diffuse into the brain. They found that the animals developed PD.
“For the first time we discovered a pathway that can cause the disease. This opens the door to find better tools to treat Parkinson’s,” said Dan Adams, chief science officer at PhotoPharmics, in a recent news release.
The investigators used the eyes as a treatment pathway to deliver minute amounts of dopamine and other medications, which resulted in a rapid symptom recovery in the animals.
Light activates retinal dopamine and suppresses melatonin. Exposing the animals to experimental light conditions produced a two-fold recovery compared to dopamine or melatonin antagonists alone.
Parkinson’s patients are photosensitive leading researchers to experiment low-intensity phototherapy for patients with PD. According to PhotoParmics, preliminary studies have shown improvement in symptoms with certain wavelengths.
The new trial currently underway in the U.S. and Europe is a randomized double-blind, parallel study, with a duration of 7 ½ months per patient. This includes a two-week baseline assessment period, six month treatment period, and one-month follow-up. The trial should be concluded by September 2016.
http://parkinsonsnewstoday.com/2016/05/25/researchers-investigate-phototherapy-parkinsons-disease/

No comments:

Post a Comment